Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. - Wikidata - awgldk - TriplyDB

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

http://www.wikidata.org/entity/Q43531288

about

Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba Comparison of bioavailability of krill oil versus fish oil and health effect N-Acyl amines of docosahexaenoic acid and other n-3 polyunsatured fatty acids - from fishy endocannabinoids to potential leads Marine omega-3 phospholipids: metabolism and biological activities.Krill products: an overview of animal studies The endocannabinoid system: directing eating behavior and macronutrient metabolism A re-evaluation of 9-HODE activity at TRPV1 channels in comparison with anandamide: enantioselectivity and effects at other TRP channels and in sensory neurons Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity Krill Oil Improves Mild Knee Joint Pain: A Randomized Control Trial Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids Cannabinoids, eating behaviour, and energy homeostasis.Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice.Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.Supplementation of diet with krill oil protects against experimental rheumatoid arthritis.Participants with Normal Weight or with Obesity Show Different Relationships of 6-n-Propylthiouracil (PROP) Taster Status with BMI and Plasma Endocannabinoids.Water-soluble extract of Pacific Krill prevents triglyceride accumulation in adipocytes by suppressing PPARγ and C/EBPα expression New insights on the role of the endocannabinoid system in the regulation of energy balance.Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects Dietary triacylglycerols with palmitic acid in the sn-2 position modulate levels of N-acylethanolamides in rat tissues Differential effects of krill oil and fish oil on the hepatic transcriptome in mice Krill oil attenuates left ventricular dilatation after myocardial infarction in rats.Redox Status and Neuro Inflammation Indexes in Cerebellum and Motor Cortex of Wistar Rats Supplemented with Natural Sources of Omega-3 Fatty Acids and Astaxanthin: Fish Oil, Krill Oil, and Algal Biomass.Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil.Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice.Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?n-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice.ω-6 Polyunsaturated fatty acids extend life span through the activation of autophagy.Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism.Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice.Nutritional properties of dietary omega-3-enriched phospholipids.Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat.Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals.The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.

P2860

Q21132308-45797D2D-C5A3-4B9D-9785-686794168B94 Q21245691-13D2BC0A-C425-4543-BE45-36FA1E1DDC93 Q24634419-52B0FD4B-2269-44A7-97D9-0D69297A7FC4 Q26781855-728206F4-6DBB-4782-B879-232E7D160B30 Q27011679-63037C4A-B700-4A61-B463-D0FE835FFA9F Q27690878-84B2D66A-A70B-443B-BFB2-CA9723E063A7 Q28081951-72DBA3A2-A89B-40C1-86DD-8BC4D92CDC44 Q28086830-A1A3CFD1-6DC1-4C12-819A-B56284F48A6C Q28272440-19F29257-811F-4D11-9CD8-B0939B624747 Q28389088-17E1C11D-7DF2-4075-B02A-30136395F5B1 Q28554476-94966E1F-0ED0-422B-81DB-74BA070C30D9 Q28728625-B0E7D4F7-4788-4771-A0B9-900D67063200 Q30357350-AB5B6334-15E5-48FD-9963-FF8D00573C3D Q33451202-D71900C2-DBFD-4FC8-8563-929CCC810F63 Q33602403-AD9E5590-6AF6-4B21-9FB0-286F9650F127 Q33619855-7F5CDB23-1428-4495-9384-6E285F5E8955 Q33683756-6B2F068F-ED44-4994-BD21-E266A2982C9D Q33961628-30C071DC-5720-4F67-868B-F4A7600C7040 Q34494301-FB123804-8E06-44F9-8FC2-546EDF724EFC Q34559890-444F8CF4-92E0-44C3-968C-8DB62A44B3A2 Q34623269-B0E85AEB-E8C7-4DE4-932A-D4C4B6A6D3E0 Q35578640-E3188BCC-A7C7-4B63-A8E3-987293F3FCD9 Q35711254-2E911EE7-EAEF-4ED9-92EA-2F72D123AE19 Q35761506-3FF70A28-13B4-476A-85D1-9C88D76A28CB Q36226736-2096E707-9AA0-408B-94C7-DBE2A7D34BC5 Q36246506-F0E50FD3-D3FB-4296-98C7-299BFB4569EC Q36300457-309E90B8-4343-4267-88C2-6E2E8CF02CC9 Q36353394-FF60F784-7A7C-4080-A348-07A539DD64FF Q36545060-4BBE829B-7E01-44EC-ACA2-E8F714E7D699 Q36620178-E97EC6E9-2A20-4EBE-901F-4085E95DE321 Q36649089-7E4F5E57-A058-4066-8D83-CECF36E8B192 Q36660198-E91453BF-4C04-45E2-886F-FFC876EB22B1 Q36731768-165B5E74-E715-414C-B7C2-6791948B87A8 Q36916109-8E43A160-C9AF-4ADC-B209-47667BF9F7D3 Q36922992-B74E8978-740A-4BAF-AEB7-E2B190FC8ECA Q37056912-70E7B0C6-E87F-46EE-B219-3AA94C7AACD0 Q37105403-537088C2-0E0D-4EDA-BACE-6B20F0FD6184 Q37683805-92E3E924-D75B-4F14-AC26-A4B10371A3ED Q37906726-DE042378-5BC0-46AD-A99C-D302C87DC1CF Q37913717-9A556A5C-9D6F-47ED-9F35-2275E8BCC4AC

P2860

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

http://www.wikidata.org/entity/Q43531288

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Endocannabinoids may mediate t ...... ediators in obese Zucker rats.

@en

Endocannabinoids may mediate the ability of

@nl

type

label

Endocannabinoids may mediate t ...... ediators in obese Zucker rats.

@en

Endocannabinoids may mediate the ability of

@nl

prefLabel

Endocannabinoids may mediate t ...... ediators in obese Zucker rats.

@en

Endocannabinoids may mediate the ability of

@nl

P1433

Q43531288-24FB1EC5-FD85-4D5A-87AF-5EEC3C401A9A

P1476

Q43531288-A520ED62-975E-43CF-835F-3FB7353303AF

P2093

Q43531288-0D9BCED1-1232-45B8-8A39-9B184DCB7535

Q43531288-1423230E-3654-4E0C-BDC7-3EC1E0A6751B

Q43531288-1F504F74-5878-49D8-8FB4-D979CE8FFAE9

Q43531288-42AF1104-2DEF-4CE6-9608-BEE60FA1A87C

Q43531288-91338D8C-C371-41C1-8E57-F2744DD5B6AF

Q43531288-B70DF772-2153-4988-B748-935F329E9C14

Q43531288-C230739A-E41A-4717-A59D-C9DF67CEEAB5

Q43531288-C94AD910-36E9-4480-B429-0CFA9C918A46

Q43531288-D640D988-0980-492D-AEDB-3DA3940E35B3

Q43531288-E28F05EC-BB02-4A7C-9E35-AA464A72A078

P304

Q43531288-1EDA234B-1488-4494-9B3A-FACE52A04DC9

P31

Q43531288-1583A7DE-A313-4C99-B0A3-E5C97065DF9E

P356

Q43531288-84424DBB-DBF6-48DF-98DD-5FC5F66F9443

P407

Q43531288-524C9902-9721-4BA7-835A-1A1CD2D545F7

P433

Q43531288-F326FAE2-065C-4F8E-84B4-527AB1F6F83C

P478

Q43531288-0643BD10-CFB8-41E3-8F2F-F0BE4ED7DC80

P50

Q43531288-799D6343-4BBA-4E4D-9A87-2DCF01A74A80

Q43531288-B4B68D4F-327F-4F44-9878-FE0545EFE82C

Q43531288-EEC73731-1615-42AA-891B-48403AAA2970

Q43531288-FF5A782B-95CD-4355-AE0D-D3E4DD8D6A94

P577

Q43531288-9C715DD4-E51E-479A-ABAD-5945E3A3D5B7

P5875

Q43531288-C6A6E8C0-EF32-4F71-81FB-98B1E3AF142F

P698

Q43531288-C25C451B-E8DB-466A-A89A-D21856514189

P921

Q43531288-322656C7-9BF7-44EE-B55C-F1F3A27733B6

Q43531288-A4BC3813-F7E2-4CB6-A436-4E9A87C03F28

Q43531288-CB6DC5C1-FB71-4E04-A1BF-B436A9C5C1DD

P356

P1433

Journal of Nutrition

P1476

Endocannabinoids may mediate t ...... mediators in obese Zucker rats

@en

P2093

Alessia Ligresti

http://www.w3.org/2001/XMLSchema#string

Elena Giordano

http://www.w3.org/2001/XMLSchema#string

Elisabetta Murru

http://www.w3.org/2001/XMLSchema#string

Francesca Sanna

http://www.w3.org/2001/XMLSchema#string

Inge Bruheim

http://www.w3.org/2001/XMLSchema#string

Lina Cordeddu

http://www.w3.org/2001/XMLSchema#string

Mikko Griinari

http://www.w3.org/2001/XMLSchema#string

Sabrina Uda

http://www.w3.org/2001/XMLSchema#string

Sebastiano Banni

http://www.w3.org/2001/XMLSchema#string

Tiziana Bisogno

http://www.w3.org/2001/XMLSchema#string

P304

1495-1501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3945/JN.109.104844

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Di Marzo

Barbara Batetta

P577

2009-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26314213

http://www.w3.org/2001/XMLSchema#string

P698

19549757

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoids